According to a New York Times article, specialists in infectious disease are protesting a huge increase in the price of a 62-year-old drug that treats life-threatening parasitic infections.
Turing Pharmaceuticals acquired the drug Daraprim in August. The company almost immediately raised the tablet price from $13.50 to $750 -- an increase of 5,000% for the course of the drugs treatment cycle -- which brings the annual cost of treatment for some patients to hundreds of thousands of dollars, the article said.
Turing’s price increase is not an isolated example. Read the full story to learn more
